Purine inhibitors of human phosphatidylinositol 3-kinase delta
申请人:Merck Sharp & Dohme Corp.
公开号:US11179389B2
公开(公告)日:2021-11-23
The instant invention provides compounds of formula I which are PI3K-delta inhibitors, and as such are useful for the treatment of PI3K-delta-mediated diseases such as inflammation, asthma, COPD and cancer.
本发明提供的式 I 化合物是 PI3K-delta 抑制剂,因此可用于治疗 PI3K-delta 介导的疾病,如炎症、哮喘、慢性阻塞性肺病和癌症。
PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA
申请人:Merck Sharp & Dohme Corp.
公开号:US20200390760A1
公开(公告)日:2020-12-17
The instant invention provides compounds of formula I which are PI3K-delta inhibitors, and as such are useful for the treatment of PI3K-delta-mediated diseases such as inflammation, asthma, COPD and cancer.
[EN] PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA<br/>[FR] INHIBITEURS PURIQUES DE LA PHOSPHATIDYLINOSITOL 3-KINASE DELTA HUMAINE
申请人:MERCK SHARP & DOHME
公开号:WO2019119207A1
公开(公告)日:2019-06-27
Provided are compounds of formula (I) which are PI3K-delta inhibitors, and as such are useful for the treatment of PI3K-delta-mediated diseases such as inflammation, asthma, COPD and cancer.